RWG
GILD icon

Regal Wealth Group’s Gilead Sciences GILD Stock Holding History

Regal Wealth Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500
Closed -$32K – 126
2021
Q1 		$32K Hold
500
– – 0.02% 114
2020
Q4 		$29K Hold
500
– – 0.02% 117
2020
Q3 		$32K Hold
500
– – 0.02% 99
2020
Q2 		$38K Buy
500
+400
+400% +$30.7K 0.03% 95
2020
Q1 		$7K Buy
+100
New +$6.91K 0.01% 138

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Regal Wealth Group's GILD Position: Q2 2021 in Review

Regal Wealth Group sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 500 shares — an estimated $32K sold.

Regal Wealth Group first reported a position in GILD in Q1 2020 and held it in 5 quarters. The position peaked at $38K in Q2 2020. 1,544 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Regal Wealth Group reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Regal Wealth Group sold 500 Gilead Sciences shares in Q2 2021, an estimated $32K.
  • Regal Wealth Group first reported a position in Gilead Sciences in Q1 2020 and held it in 5 quarters.
  • Regal Wealth Group's Gilead Sciences position peaked at $38K in Q2 2020.
  • 1,544 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Regal Wealth Group's 13F filing for Q2 2021, filed 2 Aug 2021.